CN Patent

CN101506149B — 脯氨酰羟化酶抑制剂及使用方法

Assigned to Akebia Therapeutics Inc · Expires 2012-11-14 · 14y expired

What this patent protects

本文涉及HIF-1α脯氨酰羟化酶抑制剂、包括本文所述的HIF-1α脯氨酰羟化酶抑制剂的组合物以及防治特别是周围血管疾病(PVD)、冠状动脉疾病(CAD)、心力衰竭、缺血及贫血的方法。

USPTO Abstract

本文涉及HIF-1α脯氨酰羟化酶抑制剂、包括本文所述的HIF-1α脯氨酰羟化酶抑制剂的组合物以及防治特别是周围血管疾病(PVD)、冠状动脉疾病(CAD)、心力衰竭、缺血及贫血的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101506149B
Jurisdiction
CN
Classification
—
Expires
2012-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Akebia Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.